However, down‐regulation of miR‐338 significantly promoted NSCLC cells proliferation (Figure 3b), increased the expressions of PCNA, CDK4, cyclin D1 and decreased the expression of p27 in NSCLC cells (Figure 3c). This evidence concerns the gene CDK4 and non-small cell lung carcinoma.